| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
10% Owner | Director, 10% Owner | Director
9 companies
Armistice Capital, LLC serves as a 10% Owner at HIND and has filed Form 4s across 9 companies. Across recent SEC filings that breaks down to 337 buys and 114 sells. Those positions are worth an estimated $10.1M at current prices.
Historically, Armistice Capital, LLC's trades have earned a middling insider score of 56/100 across 42 rated trades. Over a 12-month horizon, 23.8% of those trades were profitable, with an average 12-month return of -33.4%.
The biggest single holding is ACHV (~$3.7M) as 10% Owner. The recent filings there lean toward selling, a net 299,332 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jan 8, 2019 | AVTX Avalo Therapeutics, Inc. | Director, 10% Owner | Buy | 27,004 | $3.48 | $93,913.80 | +0.1% | |
| Dec 31, 2018 | AVTX Avalo Therapeutics, Inc. | Director, 10% Owner | Buy | 38,799 | $3.14 | $121,757.67 | +0.2% | |
| Dec 18, 2018 | AVTX Avalo Therapeutics, Inc. | Director, 10% Owner | Buy | 50,000 | $3.31 | $165,407.81 | +0.3% | |
| Dec 11, 2018 | KPRX Kiora Pharmaceuticals Inc | Director, 10% Owner | Buy | 107,153 | $0.40 | $43,180.92 | +0.6% | |
| Dec 10, 2018 | AVTX Avalo Therapeutics, Inc. | Director, 10% Owner | Buy | 36,400 | $3.41 | $124,145.63 | +0.2% | |
| Dec 4, 2018 | AVTX Avalo Therapeutics, Inc. | Director, 10% Owner | Buy | 25,797 | $3.49 | $90,153.37 | +0.1% | |
| Nov 29, 2018 | AVTX Avalo Therapeutics, Inc. | 10% Owner | Buy | 77,803 | $3.51 | $272,863.77 | +0.4% | |
| Nov 26, 2018 | AVTX Avalo Therapeutics, Inc. | Director, 10% Owner | Buy | 50,000 | $3.59 | $179,407.00 | +0.3% | |
| Nov 20, 2018 | AVTX Avalo Therapeutics, Inc. | Director, 10% Owner | Buy | 49,100 | $3.61 | $177,292.62 | +0.3% | |
| Nov 16, 2018 | KPRX Kiora Pharmaceuticals Inc | Director, 10% Owner | Buy | 360,000 | $0.45 | $161,395.09 | +2.1% |